Abstract | OBJECTIVE: The insulinotropic effect of exogenous, intravenously infused glucose-dependent insulinotropic polypeptide (GIP) is impaired in patients with type 2 diabetes. We evaluated the effects of endogenous GIP in relation to glucose and bone metabolism in patients with type 2 diabetes using a selective GIP receptor antagonist and hypothesized that the effects of endogenous GIP were preserved. DESIGN: A randomized, double-blinded, placebo-controlled, crossover study. METHODS: Ten patients with overweight/ obesity and type 2 diabetes (mean±s.d.; HbA1c 52 ± 11 mmol/mol; BMI 32.5 ± 4.8 kg/m2) were included. We infused a selective GIP receptor antagonist, GIP(3-30)NH2 (1200 pmol/kg/min), or placebo (saline) during two separate, 230-min, standardized, liquid mixed meal tests followed by a meal ad libitum. Subcutaneous adipose tissue biopsies were analyzed. RESULTS: Compared with placebo, GIP(3-30)NH2 reduced postprandial insulin secretion (Δbaseline-subtracted area under the curve (bsAUC) C-peptide% ± s.e.m.; -14 ± 6%, P = 0.021) and peak glucagon (Δ% ± s.e.m.; -11 ± 6%, P = 0.046) but had no effect on plasma glucose (P = 0.692). Suppression of bone resorption (assessed by circulating carboxy-terminal collagen crosslinks (CTX)) was impaired during GIP(3-30)NH2 infusion compared with placebo (ΔbsAUCCTX; ±s.e.m.; -4.9 ± 2 ng/mL × min, P = 0.005) corresponding to a ~50% reduction. Compared with placebo, GIP(3-30)NH2 did not affect plasma lipids, meal consumption ad libitum or adipose tissue triglyceride content. CONCLUSIONS: Using a selective GIP receptor antagonist during a meal, we show that endogenous GIP increases postprandial insulin secretion with little effect on postprandial glycaemia but is important for postprandial bone homeostasis in patients with type 2 diabetes.
|
Authors | Signe Stensen, Lærke S Gasbjerg, Liva L Krogh, Kirsa Skov-Jeppesen, Alexander H Sparre-Ulrich, Mette H Jensen, Flemming Dela, Bolette Hartmann, Tina Vilsbøll, Jens J Holst, Mette M Rosenkilde, Mikkel B Christensen, Filip K Knop |
Journal | European journal of endocrinology
(Eur J Endocrinol)
Vol. 185
Issue 1
Pg. 33-45
(May 21 2021)
ISSN: 1479-683X [Electronic] England |
PMID | 33886495
(Publication Type: Journal Article)
|
Chemical References |
- Blood Glucose
- Collagen Type I
- Peptide Fragments
- Peptides
- Receptors, Gastrointestinal Hormone
- Triglycerides
- collagen type I trimeric cross-linked peptide
- gastric inhibitory polypeptide (3-30)-amide
- Gastric Inhibitory Polypeptide
- gastric inhibitory polypeptide receptor
|
Topics |
- Adult
- Aged
- Blood Glucose
(drug effects, metabolism)
- Bone Resorption
(metabolism)
- Collagen Type I
(drug effects, metabolism)
- Cross-Over Studies
- Diabetes Mellitus, Type 2
(metabolism)
- Double-Blind Method
- Feeding Behavior
(drug effects)
- Gastric Inhibitory Polypeptide
(metabolism, pharmacology)
- Humans
- Insulin Secretion
(drug effects, physiology)
- Male
- Middle Aged
- Obesity
(metabolism)
- Peptide Fragments
(pharmacology)
- Peptides
(drug effects, metabolism)
- Postprandial Period
- Random Allocation
- Receptors, Gastrointestinal Hormone
(antagonists & inhibitors)
- Subcutaneous Fat
(drug effects, metabolism)
- Triglycerides
(metabolism)
|